These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 20039736)

  • 41. Influence of chelating agents on biogenic uraninite reoxidation by Fe(III) (Hydr)oxides.
    Stewart BD; Girardot C; Spycher N; Sani RK; Peyton BM
    Environ Sci Technol; 2013 Jan; 47(1):364-71. PubMed ID: 23163577
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Formation of iron nanoparticles and increase in iron reactivity in mineral dust during simulated cloud processing.
    Shi Z; Krom MD; Bonneville S; Baker AR; Jickells TD; Benning LG
    Environ Sci Technol; 2009 Sep; 43(17):6592-6. PubMed ID: 19764222
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Use of Microfocused X-ray Techniques to Investigate the Mobilization of As by Oxalic Acid.
    Wovkulich K; Mailloux BJ; Bostick BC; Dong H; Bishop ME; Chillrud SN
    Geochim Cosmochim Acta; 2012 Aug; 91():254-270. PubMed ID: 23175572
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Transformation of siderite to goethite by humic acid in the natural environment.
    Xing B; Graham N; Yu W
    Commun Chem; 2020 Mar; 3(1):38. PubMed ID: 36703449
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Building bottom-up aggregate-based models (ABMs) in soil systems with a view of aggregates as biogeochemical reactors.
    Wang B; Brewer PE; Shugart HH; Lerdau MT; Allison SD
    Glob Chang Biol; 2019 Aug; 25(8):e6-e8. PubMed ID: 31087714
    [No Abstract]   [Full Text] [Related]  

  • 46. Consider the Anoxic Microsite: Acknowledging and Appreciating Spatiotemporal Redox Heterogeneity in Soils and Sediments.
    Lacroix EM; Aeppli M; Boye K; Brodie E; Fendorf S; Keiluweit M; Naughton HR; Noël V; Sihi D
    ACS Earth Space Chem; 2023 Sep; 7(9):1592-1609. PubMed ID: 37753209
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Transient O
    Wilmoth JL; Moran MA; Thompson A
    Microbiome; 2018 Oct; 6(1):189. PubMed ID: 30352628
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Model-Based Interpretation of Groundwater Arsenic Mobility during in Situ Reductive Transformation of Ferrihydrite.
    Stolze L; Zhang D; Guo H; Rolle M
    Environ Sci Technol; 2019 Jun; 53(12):6845-6854. PubMed ID: 31117535
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Competing Fe (II)-induced mineralization pathways of ferrihydrite.
    Hansel CM; Benner SG; Fendorf S
    Environ Sci Technol; 2005 Sep; 39(18):7147-53. PubMed ID: 16201641
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Transport implications resulting from internal redistribution of arsenic and iron within constructed soil aggregates.
    Masue-Slowey Y; Kocar BD; Jofré SA; Mayer KU; Fendorf S
    Environ Sci Technol; 2011 Jan; 45(2):582-8. PubMed ID: 21158450
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Kinetics of Fe(II)-catalyzed transformation of 6-line ferrihydrite under anaerobic flow conditions.
    Yang L; Steefel CI; Marcus MA; Bargar JR
    Environ Sci Technol; 2010 Jul; 44(14):5469-75. PubMed ID: 20553044
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Contact with soil impacts ferrihydrite and lepidocrocite transformations during redox cycling in a paddy soil.
    Schulz K; Notini L; Grigg ARC; Kubeneck LJ; Wisawapipat W; ThomasArrigo LK; Kretzschmar R
    Environ Sci Process Impacts; 2023 Dec; 25(12):1945-1961. PubMed ID: 37971060
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Spatial patterns and modeling of reductive ferrihydrite transformation observed in artificial soil aggregates.
    Pallud C; Kausch M; Fendorf S; Meile C
    Environ Sci Technol; 2010 Jan; 44(1):74-9. PubMed ID: 20039736
    [TBL] [Abstract][Full Text] [Related]  

  • 54.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 55.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 56.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 57.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 3.